Buy Rating Affirmed for ADC Therapeutics on Strong Zynlonta Clinical Data and Strategic Growth Outlook
TipRanksMay 7 20:14
ADC Therapeutics Analyst Ratings
BenzingaMay 7 18:27
HC Wainwright & Co. Maintains Buy on ADC Therapeutics, Lowers Price Target to $8
BenzingaMay 7 18:29
ADC Therapeutics Analyst Ratings
BenzingaApr 15 19:50
Buy Rating Affirmed for ADC Therapeutics on Strong Preclinical Data and Promising Trial Progress
TipRanksApr 15 18:16
Analysts Conflicted on These Healthcare Names: ADC Therapeutics (ADCT), Adial Pharmaceuticals (ADIL) and Steris (STE)
TipRanksApr 11 23:30
ADC Therapeutics Analyst Ratings
BenzingaApr 5 21:53
Analysts' Top Healthcare Picks: ADC Therapeutics (ADCT), TFF Pharmaceuticals (TFFP)
TipRanksApr 5 01:20
ADC Therapeutics Analyst Ratings
BenzingaMar 28 18:44
Analysts Conflicted on These Healthcare Names: Veradigm (OtherMDRX), ADC Therapeutics (ADCT) and Sangamo Biosciences (SGMO)
TipRanksMar 16 09:50
ADC Therapeutics Analyst Ratings
BenzingaMar 14 23:10
Jefferies Cuts ADC Therapeutics Stock Target to $13, Maintains Buy
InvestingMar 14 04:20
Analysts Offer Insights on Healthcare Companies: ADC Therapeutics (ADCT) and Cresco Labs (OtherCRLBF)
TipRanksMar 14 01:30
ADC Therapeutics Analyst Ratings
BenzingaMar 6 21:09
ADC Therapeutics Analyst Ratings
BenzingaFeb 26 23:16
RBC Lifts Price Target on ADC Therapeutics to $8 From $6, 'Encouraged' by Competitive Positioning; Outperform, Speculative Risk Kept
MT NewswiresFeb 26 20:43
ADC Therapeutics Analyst Ratings
BenzingaFeb 20 20:21
Buy Rating Affirmed for ADC Therapeutics With Raised Price Target Amid Promising Clinical Trials and Strong Balance Sheet
TipRanksFeb 20 19:27
RBC Capital Keeps Their Buy Rating on ADC Therapeutics (ADCT)
TipRanksJan 6 09:47
Optimistic Outlook: Buy Rating for ADC Therapeutics Amid Anticipated Clinical Milestones and Strong Financials
TipRanksJan 5 19:31
No Data
No Data